|
Form Serial Number: |
DB20170818E00042 |
1.
Date of relevant event: |
16/08/2017 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
00001 |
4.
Name of listed corporation: |
CK Hutchison Holdings Limited |
5.
Name of associated corporation of listed corporation: |
Hutchison China MediTech Limited |
6.
Registered office: |
P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands |
7.
Principal place of business: |
22nd Floor, Hutchison House, 10 Harcourt Road, Hong Kong |
8.
Class of shares in which interested: |
Ordinary |
9.
Number of issued shares in class: |
60,737,204 |
12.
Exchange on which listed: |
London Stock Exchange and Nasdaq Global Select Market |
13.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Shih |
(Other names) |
Edith |
|
|
|
16.
Name of director (Chinese): |
施熙德 |
17.
Chinese Character Code as printed on HKID Card: |
245735561795 |
|
30.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
Long position |
11031 | The number of shares in which you are interested has increased because: you became the holder of, wrote or issued equity derivatives under which (choose one): you have a right to take the underlying shares |
|
|
|
1,266 |
USD |
49.6000 |
49.4985 |
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
|
31.
Total shares immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 115,332 | 0.18 |
|
|
32.
Total shares immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 116,598 | 0.19 |
|
|
33.
Capacity in which interests disclosed in Box 32 are held: |
Capacity code | Number of shares |
| |
|
|
34.
Further information in derivative interests in associated corporation: |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by associated corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
Long position | 4104 | Listed derivatives - Other (you must describe the category of derivatives in the Supplementary Information box) |
| | | | | | | | | 1,266 |
|
|
35.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
36.
Further information in relation to interests of corporations controlled by director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
37.
Further information in relation to interests held by director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
| | |
|
|
38.
Further information from a trustee, a beneficiary of a trust, or a person who has set up a discretionary trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
39.
Supplementary information: |
The equity derivatives represent the American Depositary Shares ("ADS") which are traded on the Nasdaq Global Select Market. Each ADS equates to 0.5 ordinary share.
|
40.
Log/Serial Number of the previous form: |
|
Date of filing this Form 3B: |
18/08/2017 (dd/mm/yyyy)
|
|